NovaGold (NG) director Erfan Ali granted 36,600 stock options at $8.73

Rhea-AI Filing Summary

NovaGold Resources director Erfan Ali received a new stock option grant. On 02/02/2026, he was awarded options to purchase 36,600 common shares at an exercise price of $8.73 per share. The options were granted at no cost and are held directly.

The options vest in three equal installments: one-third on 02/02/2027, one-third on 02/02/2028, and the final one-third on 02/02/2029. Following this grant, Ali beneficially owns 36,600 stock options, giving him potential future equity exposure to NovaGold Resources if exercised.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Erfan Ali

(Last) (First) (Middle)

C/O NOVAGOLD RESOURCES INC.

201 SOUTH MAIN STREET, SUITE 400

(Street)

SALT LAKE CITY UT 84111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOVAGOLD RESOURCES INC [ NG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.73	02/02/2026		A		36,600		(1)	02/01/2031	Common Shares	36,600	$0	36,600	D

Explanation of Responses:

1. The options vest as follows: 1/3 on 02/02/2027; 1/3 on 02/02/2028; and 1/3 on 02/02/2029.

Remarks:

	/s/ Ali Erfan	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NovaGold (NG) report for Erfan Ali on February 2, 2026?

NovaGold reported that director Erfan Ali received a grant of stock options on 02/02/2026. He was awarded 36,600 options to buy NovaGold common shares at an exercise price of $8.73 per share, with no purchase price for the option itself.

How many NovaGold (NG) stock options does Erfan Ali beneficially own after this filing?

After the reported transaction, director Erfan Ali beneficially owns 36,600 stock options. These options give him the right to purchase the same number of NovaGold common shares at an exercise price of $8.73 per share if and when he chooses to exercise them.

What is the vesting schedule for Erfan Ali’s NovaGold (NG) stock options?

The 36,600 stock options granted to director Erfan Ali vest in three equal installments. One-third vests on 02/02/2027, another third on 02/02/2028, and the final third on 02/02/2029, aligning vesting with multi-year service to NovaGold.

What is the exercise price of the stock options granted to NovaGold (NG) director Erfan Ali?

The stock options granted to director Erfan Ali carry an exercise price of $8.73 per share. This means he can buy NovaGold common shares at $8.73 each upon exercise, subject to vesting and before the options’ stated expiration date of 02/01/2031.

When do Erfan Ali’s NovaGold (NG) stock options expire if unexercised?

The reported stock options granted to director Erfan Ali expire on 02/01/2031 if not exercised. He can exercise vested portions any time before that date, subject to company policies and applicable securities regulations governing insider transactions.